MedPath

Healing comfort and bone health in dental implants conventional versus flapless approach

Phase 4
Not yet recruiting
Conditions
Chronic periodontitis,
Registration Number
CTRI/2025/05/087825
Lead Sponsor
Dr Sankha Subhra Roy
Brief Summary

The purpose of this study is to compare marginal bone loss and soft tissue changes around implant and pain analgesic and swelling  assessments at baseline and 3 months. The null hypothesis is that there is no significant difference between the two treatment modalities.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
20
Inclusion Criteria

Age should be above or equals to 18 years Patient with partially edentulous area with minimum 5mm bone width and 8 mm bone length in maxilla or mandible Systematically healthy male and female with co operative ones should be included.

Exclusion Criteria

Patients having any adverse habits like smiking alcohol consumption Pregnant or lactating woman Uncontrolled systemic disease Allergy or hypersensitivity to any product used Mental or physical disorder Patients on bisphosphonates any evidence of pathology or active diseases of the implant bed and atrophy requiring bone regeneration in both width and height were excluded from the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
A clinicoradiological evaluation of marginal bone loss tissue changes post operative patients compliance in implants placed with flapless versus conventional surgical techniqueBaseline and 3 months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Maharishi markandeshwar college of dental sciences and research

🇮🇳

Ambala, HARYANA, India

Maharishi markandeshwar college of dental sciences and research
🇮🇳Ambala, HARYANA, India
Dr Sankha Subhra Roy
Principal investigator
09310693160
perioprecision23roy@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.